Center for Bioethics / People / Lerman
Caryn Lerman
Professor of Psychology in Psychiatry
Mary W. Calkins Professor, Annenberg School for Communication, University of Pennsylvania
Deputy Director, Abramson Cancer Center, University of Pennsylvania
Department: Psychiatry
Contact information
Center for Interdisciplinary Research on Nicotine Addiction (CIRNA)
3535 Market Street, Suite 4100
Philadelphia, PA 19104
3535 Market Street, Suite 4100
Philadelphia, PA 19104
Office: 215-746-7141
Fax: 215-746-7140
Fax: 215-746-7140
Email:
clerman@mail.med.upenn.edu
clerman@mail.med.upenn.edu
Graduate Group Affiliations
Education:
B.S. (Psychology)
Pennsylvania State University , 1981.
M.S. (Psychology)
University of Southern California , 1982.
Ph.D. (Clinical Psychology)
University of Southern California , 1984.
(Internship in Clinical/Medical Psychology)
Boston Veterans Administration Medical Center , 1985.
Permanent linkB.S. (Psychology)
Pennsylvania State University , 1981.
M.S. (Psychology)
University of Southern California , 1982.
Ph.D. (Clinical Psychology)
University of Southern California , 1984.
(Internship in Clinical/Medical Psychology)
Boston Veterans Administration Medical Center , 1985.
Selected Publications
Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead J, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. : Human mu opioid receptor (OPRM1 A118G) polymorphism is associated with brain mu opiod receptor binding potential in smokers. Proceedings of the National Academy of Sciences USA Epub ahead of print, 2011.Schnoll RA, Cappella J, Lerman C, Pinto A, Patterson F, Wileyto P, Bigman C, Leone F.: A novel recruitment message to increase enrollment into a smoking cessation treatment program: Preliminary results from a randomized trial. Health Communication Epub ahead of print, 2011.
Perkins KA, Lerman C.: Early human screening of medications to treat drug addiction: novel paradigms and the relevance of pharmacogenetics. Clinical Pharmacology and Therapeutics 89(3): 460-463, 2011.
Lee S, Capella JN, Lerman C, Strasser AA.: Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine and Tobacco Research 13(4): 282-290, 2011.
Javitz HS, Swan GE, Lerman C.: The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. Addiction Epub ahead of print, 2011.
Mrazek DA, Lerman C. : Pharmacogenomics: facilitating clinical implementation. Journal of the American Medical Association 306(3): 304-305, 2011.
Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale R, Benowitz NL, Lerman C, Conti DV.: Gender stratified gene and gene-treatment interactions in smoking cessation. The Pharmacogenomics Journal Epub ahead of print, 2011.
King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW.: Smoking cessation pharmacogenetics: analysis of varenicline and buproprion in placebo-controlled clinical trials. Neuropsychopharmacology Epub ahead of print, 2011.
Schnoll RA, Wileyto EP, Lerman C.: Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addictive Behavior Epub ahead of print, 2011.
Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale R, Lerman, C, Ray, R.: Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine and Tobacco Research Epub ahead of print, 2011.